Intrommune Therapeutics

Updated: May 22

Presented by Abhit Singh, MD, MHA VP, Medical Affairs, Intrommune Therapeutics

Intrommune Therapeutics is a specialty bio-pharmaceutical company located in New York, NY. Intrommune is developing a revolutionary new treatment platform for food allergies that is safe, effective and convenient. Intrommune’s first product is a therapy for patients who suffer fro​m peanut allergy. Intrommune is developing the oral mucosal immunotherapy (OMIT) platform for food allergies. It is a long-term solution for the 220 million, including 9 million U.S. adults and 6 million U.S. children, who suffer from this life-altering condition.

12 views0 comments

Recent Posts

See All

InnovatorMD © 2021 . Created on Editor X.

We serve all members of the healthcare innovation ecosystem whether you are a subject matter expert, a student, an entrepreneur, a startup, a business person, a service provider, an investor or a sponsor.

Sign Up To Our Newsletter

Thanks for submitting!

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube



The Largest Physician Innovation Online Event

Speakers, Startups, Scientific Sessions, CME

Location: San Francisco & Online   

Date: AUG 5-7 2021